You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY22 is not expected to be complete until September, 2023.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
-
PSO ACTUARIAL RATE MODEL FOR MEDICARE RISK CONTRACTS
SBC: Actuarial Research Corporation Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
CHIN DRY--TECHNOLOGY TO HELP CONTROL PROBLEM DROOLING
SBC: INNOVATIVE HUMAN SERVICES, INC. Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
ENDOGENOUS STENT FOR POSTANGIOPLASTY VASCULAR REPAIR
SBC: Microbiomed Corporation Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
ELECTRONIC RISK ASSESSMENT WORKBOOK (NIEHS NUMBER 73)
SBC: Lb&m Assoc., Inc. Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
HUMAN IMPLANTATION OF A TELEMETRIC ICP SENSOR
SBC: Lifesensors, Inc. Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
HEART RATE VARIABILITY ANALYSIS USING POLYNOMIAL NETWORK
SBC: ABTECH CORPORATION Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
SENSITIVE AUTOMATED HYPHENATED SFE/GC/MS
SBC: Durability, Inc., Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
PSEUDOVIRAL RNA STANDARDS
SBC: AMBION DIAGNOSTICS, INC. Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
PORTABLE MULTIMEDIA FOR FAMILY CAREGIVER TRAINING
SBC: American Research Corporation of Virginia Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
IDENTIFICATION OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGENS
SBC: Argonex, Inc. Topic: N/AIn the last several years there has been an explosion of information regarding the nature of peptide antigens expressed on human tumors together with class I molecules encoded in the Major Histocompatibility Complex (MHC) and recognized by cytotoxic T lymphocytes (CTL). One very successful approach aimed at the identification of these antigens, termed Direct Identification of Relevant Epitopes for ...
SBIR Phase I 1997 Department of Health and Human Services